Skip to search formSkip to main contentSkip to account menu

montelukast sodium

Known as: Cyclopropaneacetic Acid, 1-((((1R)-1-(3-((1E)-2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)-, Monosodium Salt, sodium 1-(((1-(3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropylacetate 
The orally bioavailable monosodium salt of montelukast, a selective cysteinyl leukotriene receptor antagonist with anti-inflammatory and… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
In order to define an enantioselective nuclear magnetic resonance (NMR) method for the antiasthmatic drug montelukast, a series… 
2012
2012
Aim of the present work was to formulate and evaluate an oral, time controlled drug delivery system of Montelukast sodium, based… 
2011
2011
A simple, accurate, and precise AUC curve spectrophotometric method was developed for simultaneous determination of Montelukast… 
2010
2010
Sophisticated analytical methods viz. HPLC and HPTLC which are being employed for analysis are relatively expensive and hence… 
Review
2008
Review
2008
Exercise is the most common trigger of bronchospasm in children with asthma. Exercise-induced bronchoconstriction (EIB) occurs in… 
2006
2006
Sjögren-Larsson syndrome is a rare hereditary metabolic disorder characterized by congenital ichthyosis, mental retardation, and… 
2005
2005
BACKGROUND It is currently recommended that leukotriene modifiers (receptor antagonists and synthesis inhibitors) be withheld for… 
2003
2003
OBJECTIVE To compare the effectiveness of an intranasal steroid treatment with that of the combination of a histamine1 receptor…